Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] AOCI Attributable to Parent [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Balances (in shares) at Jun. 30, 2018				37,608,000
Balances at Jun. 30, 2018	$ 25,276	$ (24,682)	$ 594	$ 376	$ 246,568	$ 876,931	$ (44,814)	$ 0	$ 1,079,061
Net earnings						96,072			96,072
Other comprehensive income (loss)							(14,024)		(14,024)
Share repurchases (in shares)				(95,000)
Share repurchases				$ (1)		(15,404)			$ (15,405)
Common stock issued for exercise of options (in shares)				382,000					383,000
Common stock issued for exercise of options				$ 4	36,272				$ 36,276
Common stock issued for restricted stock awards (in shares)				29,000
Common stock issued for restricted stock awards				$ 0		(2,575)			(2,575)
Cash dividends						(48,366)			(48,364)
Stock-based compensation expense					31,775				31,775
Common stock issued to employee stock purchase plan (in shares)				10,000
Common stock issued to employee stock purchase plan				$ 0	1,676				1,676
Employee stock purchase plan expense					505				505
Balances (in shares) at Jun. 30, 2019				37,934,000
Balances at Jun. 30, 2019	(879)		(879)	$ 379	316,797	931,934	(83,521)	0	1,165,589
Net earnings						229,296			229,296
Other comprehensive income (loss)							(13,678)		$ (13,678)
Share repurchases (in shares)				(279,000)					(279,381)
Share repurchases				$ (3)		(50,109)			$ (50,112)
Common stock issued for exercise of options (in shares)				730,000					743,000
Common stock issued for exercise of options				$ 7	69,461	(1,642)			$ 67,826
Common stock issued for restricted stock awards (in shares)				56,000
Common stock issued for restricted stock awards				$ 1	(1)	(2,229)			(2,228)
Cash dividends						(48,902)			(48,902)
Stock-based compensation expense					31,932				31,932
Common stock issued to employee stock purchase plan (in shares)				14,000
Common stock issued to employee stock purchase plan				$ 0	2,312				2,312
Employee stock purchase plan expense					435				435
Surrender and retirement of stock to exercise option (in shares)				(2,000)
Surrender and retirement of stock to exercise option				$ 0	(400)				$ (400)
Balances (in shares) at Jun. 30, 2020				38,453,000					38,453,046
Balances at Jun. 30, 2020	$ (276)		$ (276)	$ 385	420,536	1,057,470	(97,199)	0	$ 1,381,192
Net earnings						140,410		(825)	139,585
Other comprehensive income (loss)							39,908	103	$ 40,011
Share repurchases (in shares)				(120,000)					(120,000)
Share repurchases				$ (1)		(43,177)			$ (43,178)
Common stock issued for exercise of options (in shares)				573,000					627,000
Common stock issued for exercise of options				$ 6	62,102	(12,287)			$ 49,821
Common stock issued for restricted stock awards (in shares)				38,000
Common stock issued for restricted stock awards				$ 0	(0)	(7,057)			(7,057)
Cash dividends						(49,622)			(49,622)
Stock-based compensation expense					48,065				48,065
Common stock issued to employee stock purchase plan (in shares)				11,000
Common stock issued to employee stock purchase plan				$ 0	2,791				2,791
Employee stock purchase plan expense					917				917
Non-controlling interest in Eminence								8,985	$ 8,985
Balances (in shares) at Jun. 30, 2021				38,955,000					38,955,484
Balances at Jun. 30, 2021				$ 390	$ 534,411	$ 1,085,461	$ (57,291)	$ 8,263	$ 1,571,234